Sarepta Therapeutics,, Inc. Common Stock SRPT
$18.10
-1.74%
at last close
Analyst Consensus
- Consensus Rating
- Hold (7 Buy · 4 Hold · 5 Sell)
- Average Price Target
- $23.47
- Implied Upside
- +29.7%
- Price Target Range
- $5.00 – $50.00
- Analysts (12 mo)
- 16
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| 2026-07-09 | Piper SandlerBiren Amin |
Maintains | Neutral | $23 → $20 |
| 2026-07-09 | Wolfe ResearchAndy Chen |
Upgrades | Peer perform → Outperform | $27 |
| 2026-04-16 | HC Wainwright & Co.Mitchell S. Kapoor |
Reiterates | Sell | $5 |
| 2026-03-26 | CitigroupYigal Nochomovitz |
Maintains | Sell | $9 → $13 |
| 2026-03-26 | NeedhamGil Blum |
Reiterates | Underperform | — |
| 2026-03-19 | OppenheimerKostas Biliouris |
Reiterates | Outperform | $37 |
| 2026-03-13 | MizuhoUy Ear |
Maintains | Outperform | $26 → $31 |
| 2026-03-10 | CitigroupYigal Nochomovitz |
Maintains | Sell | $8 → $9 |
| 2026-03-02 | HC Wainwright & Co.Mitchell S. Kapoor |
Reiterates | Sell | $5 |
| 2026-02-27 | Wells FargoYanan Zhu |
Maintains | Overweight | $45 → $38 |
| 2026-01-27 | HC Wainwright & Co.Mitchell S. Kapoor |
Reiterates | Sell | $5 |
| 2026-01-23 | WedbushYun Zhong |
Maintains | Outperform | $32 → $34 |
| 2026-01-14 | HC Wainwright & Co.Mitchell S. Kapoor |
Reiterates | Sell | $5 |
| 2025-12-09 | WedbushYun Zhong |
Initiates coverage on | Outperform | $32 |
| 2025-11-05 | BarclaysGena Wang |
Maintains | Equal-weight | $22 → $20 |
| 2025-11-05 | Wells FargoYanan Zhu |
Maintains | Overweight | $50 → $45 |
| 2025-11-05 | GuggenheimDebjit Chattopadhyay |
Maintains | Buy | $22 → $19 |
| 2025-11-05 | MizuhoUy Ear |
Upgrades | Neutral → Outperform | $19 → $26 |
| 2025-11-04 | BairdBrian Skorney |
Maintains | Neutral | $21 → $15 |
| 2025-10-30 | Piper SandlerBiren Amin |
Maintains | Neutral | $15 → $16 |
| 2025-09-22 | BMO CapitalKostas Biliouris |
Upgrades | Market perform → Outperform | $50 |
| 2025-09-15 | GuggenheimDebjit Chattopadhyay |
Reiterates | Buy | $22 |
| 2025-09-09 | Leerink PartnersJoseph Schwartz |
Maintains | Market perform | $12 → $15 |
| 2025-08-25 | HC Wainwright & Co.Mitchell S. Kapoor |
Reiterates | Sell | $5 |
| 2025-08-21 | B of A SecuritiesTazeen Ahmad |
Maintains | Underperform | $17 → $16 |
| 2025-08-20 | B of A SecuritiesTazeen Ahmad |
Maintains | Underperform | $10 → $17 |
| 2025-08-15 | Deutsche BankDavid Hoang |
Maintains | Sell | $6 → $12 |
| 2025-08-07 | Goldman SachsSalveen Richter |
Maintains | Neutral | $10 → $19 |
| 2025-08-07 | Wells FargoYanan Zhu |
Maintains | Overweight | $48 → $50 |
| 2025-07-30 | BarclaysGena Wang |
Upgrades | Underweight → Equal-weight | $10 → $22 |
Ratings and price targets reflect each firm's most recent published action. Consensus combines the latest call from every covering firm over the past 12 months; price targets are typically 12-month horizons.
Key Stats
- Last Close
- $18.10
- Market Cap
- $1.94 billion
- 52-Week Range
- $10.41 – $25.32
- Average Volume
- 3.07 million shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.